Insider holders · CIK 0001362703
OncBioMune Pharmaceuticals, Inc · OBMP
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Constantin DietrichChief Executive Officer | 35,848,272 | 0 | 35,848,272 | May 21, 2015 · 4:17 pm EDT | Form 4 |
| Robert Lange Elliot Jr.Director | 16,926,079 | — | 16,926,079 | Feb 4, 2016 · 5:14 pm EST | Form 4 |
| Robert Neal HolcombDirector | 6,420,000 | — | 6,420,000 | May 22, 2018 · 5:23 pm EDT | Form 3 |
| Andrew Albert KucharchukCFO & President | 5,000,000 | — | 5,000,000 | Feb 4, 2016 · 5:07 pm EST | Form 4 |
| Jonathan Frederick HeadChief Excecuite Officer | 2,892,000 | — | 2,892,000 | Apr 20, 2017 · 8:44 am EDT | Form 4/A |
| Carlos Fernando Alaman VolnieChief Operating Officer-Vitel | — | 2,500,000 | 2,500,000 | Mar 20, 2017 · 6:05 am EDT | Form 3 |
| Manuel Cosme OdabachianGlobal Operations GM-Vitel | — | 2,500,000 | 2,500,000 | Mar 20, 2017 · 6:05 am EDT | Form 3 |
| American Capital Ventures, Inc.10% Owner | 982,165 | — | 982,165 | Sep 15, 2015 · 6:04 am EDT | Form 4 |
| Leone Group, LLC10% Owner | 982,165 | — | 982,165 | Sep 15, 2015 · 6:06 am EDT | Form 4 |
| Daniel S. HovermanDirector | 60,000 | — | 60,000 | Feb 19, 2016 · 11:20 am EST | Form 4 |
| Charles L Rice Jr.Director | 60,000 | — | 60,000 | Apr 20, 2017 · 8:51 am EDT | Form 4 |
| Joseph CarusoneVP, Investor Relations# | 0 | — | 0 | Mar 18, 2015 · 5:06 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.